The HMG-box transcription factor 1/TIMP metallopeptidase inhibitor 3/PTEN axis inhibits the tumorigenesis of breast cancer and promotes the sensitivity of breast cancer to radiotherapy and hormone therapy 30. This evidence concerns the gene PTEN and breast cancer.